Aspirin as an Ultraviolet (UV) Protectant in Human Subjects at Risk for Melanoma
NCT04066725
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
95
Enrollment
OTHER
Sponsor class
Conditions
Melanoma (Skin)
Interventions
DRUG:
Aspirin 81 mg
DRUG:
Aspirin 325mg
DRUG:
Placebo oral tablet
Sponsor
University of Utah